{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:08:29Z","timestamp":1789704509032,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundamental Research Funds for the Central Public Welfare Research Institutes","award":["ZZ14-YQ-019"],"award-info":[{"award-number":["ZZ14-YQ-019"]}]},{"name":"Key Program of Tibet Autonomous Region Natural Science Foundation","award":["XZ202401ZR0074"],"award-info":[{"award-number":["XZ202401ZR0074"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360962"],"award-info":[{"award-number":["82360962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Xizang Autonomous Region Science and Technology Plan Projects","award":["XZ202501ZY0069"],"award-info":[{"award-number":["XZ202501ZY0069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"DOI":"10.1007\/s12010-026-05926-0","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:51:18Z","timestamp":1789703478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shaoyao Decoction Inhibits Colorectal Cancer Progression by Targeting PD-L1 to Reprogram the Immunosuppressive Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Xiaoyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoga","family":"Mima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujie","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"3","key":"5926_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: a cancer journal for clinicians"},{"issue":"3","key":"5926_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023). Colorectal cancer statistics, 2023. CA: a cancer journal for clinicians, 73(3), 233\u2013254. https:\/\/doi.org\/10.3322\/caac.21772","journal-title":"CA: a cancer journal for clinicians"},{"key":"5926_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","volume":"30","author":"RM Steinman","year":"2012","unstructured":"Steinman, R. M. (2012). Decisions about dendritic cells: past, present, and future. Annual review of immunology, 30, 1\u201322. https:\/\/doi.org\/10.1146\/annurev-immunol-100311-102839","journal-title":"Annual review of immunology"},{"issue":"10","key":"5926_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/ecco-jcc\/jjae061","volume":"18","author":"DA Mu\u00f1iz Pedrogo","year":"2024","unstructured":"Mu\u00f1iz Pedrogo, D. A., Sears, C. L., & Melia, J. M. P. (2024). Colorectal Cancer in Inflammatory Bowel Disease: A Review of the Role of Gut Microbiota and Bacterial Biofilms in Disease Pathogenesis. Journal of Crohn\u2019s & colitis, 18(10), 1713\u20131725. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae061","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"1","key":"5926_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s12885-020-07075-x","volume":"20","author":"X Yang","year":"2020","unstructured":"Yang, X., Wu, W., Pan, Y., Zhou, Q., Xu, J., & Han, S. (2020). Immune-related genes in tumor-specific CD4\u2009+\u2009and CD8\u2009+\u2009T cells in colon cancer. BMC cancer, 20(1), 585. https:\/\/doi.org\/10.1186\/s12885-020-07075-x","journal-title":"BMC cancer"},{"issue":"12","key":"5926_CR6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","volume":"4","author":"DY Wang","year":"2018","unstructured":"Wang, D. Y., Salem, J. E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., Rathmell, W. K., Ancell, K. K., Balko, J. M., Bowman, C., Davis, E. J., Chism, D. D., Horn, L., Long, G. V., Carlino, M. S., Lebrun-Vignes, B., & Johnson, D. B. (2018). Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. JAMA oncology, 4(12), 1721\u20131728. https:\/\/doi.org\/10.1001\/jamaoncol.2018.3923","journal-title":"JAMA oncology"},{"issue":"328","key":"5926_CR7","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D., & Chen, L. (2016). PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science translational medicine, 8(328), 328rv4. https:\/\/doi.org\/10.1126\/scitranslmed.aad7118","journal-title":"Science translational medicine"},{"key":"5926_CR8","doi-asserted-by":"publisher","first-page":"101851","DOI":"10.1016\/j.tranon.2023.101851","volume":"40","author":"X Chen","year":"2024","unstructured":"Chen, X., Chen, L. J., Peng, X. F., Deng, L., Wang, Y., Li, J. J., Guo, D. L., & Niu, X. H. (2024). Anti-PD-1\/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations. Translational oncology, 40, 101851. https:\/\/doi.org\/10.1016\/j.tranon.2023.101851","journal-title":"Translational oncology"},{"key":"5926_CR9","doi-asserted-by":"publisher","first-page":"1485303","DOI":"10.3389\/fimmu.2024.1485303","volume":"15","author":"D Song","year":"2024","unstructured":"Song, D., Hou, S., Ma, N., Yan, B., & Gao, J. (2024). Efficacy and safety of PD-1\/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis. Frontiers in immunology, 15, 1485303. https:\/\/doi.org\/10.3389\/fimmu.2024.1485303","journal-title":"Frontiers in immunology"},{"key":"5926_CR10","doi-asserted-by":"publisher","first-page":"1403533","DOI":"10.3389\/fimmu.2024.1403533","volume":"15","author":"S Yan","year":"2024","unstructured":"Yan, S., Wang, W., Feng, Z., Xue, J., Liang, W., Wu, X., Tan, Z., Zhang, X., Zhang, S., Li, X., & Zhang, C. (2024). Immune checkpoint inhibitors in colorectal cancer: limitation and challenges. Frontiers in immunology, 15, 1403533. https:\/\/doi.org\/10.3389\/fimmu.2024.1403533","journal-title":"Frontiers in immunology"},{"issue":"1","key":"5926_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00384-024-04790-w","volume":"40","author":"V Kaviyarasan","year":"2024","unstructured":"Kaviyarasan, V., Das, A., Deka, D., Saha, B., Banerjee, A., Sharma, N. R., Duttaroy, A. K., & Pathak, S. (2024). Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective. International journal of colorectal disease, 40(1), 1. https:\/\/doi.org\/10.1007\/s00384-024-04790-w","journal-title":"International journal of colorectal disease"},{"issue":"1","key":"5926_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10238-024-01408-x","volume":"24","author":"H Yu","year":"2024","unstructured":"Yu, H., Liu, Q., Wu, K., & Tang, S. (2024). Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis. Clinical and experimental medicine, 24(1), 143. https:\/\/doi.org\/10.1007\/s10238-024-01408-x","journal-title":"Clinical and experimental medicine"},{"key":"5926_CR13","doi-asserted-by":"publisher","first-page":"112600","DOI":"10.1016\/j.jep.2020.112600","volume":"252","author":"X Wang","year":"2020","unstructured":"Wang, X., Saud, S. M., Wang, F., He, S., Zhang, X., Hua, B., & Li, W. (2020). Protective effect of ShaoYao decoction on colitis-associated colorectal cancer by inducing Nrf2 signaling pathway. Journal of ethnopharmacology, 252, 112600. https:\/\/doi.org\/10.1016\/j.jep.2020.112600","journal-title":"Journal of ethnopharmacology"},{"key":"5926_CR14","doi-asserted-by":"publisher","first-page":"111981","DOI":"10.1016\/j.jep.2019.111981","volume":"241","author":"X Wang","year":"2019","unstructured":"Wang, X., Saud, S. M., Zhang, X., Li, W., & Hua, B. (2019). Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1-Nrf2-ARE signaling pathway. Journal of ethnopharmacology, 241, 111981. https:\/\/doi.org\/10.1016\/j.jep.2019.111981","journal-title":"Journal of ethnopharmacology"},{"key":"5926_CR15","doi-asserted-by":"publisher","first-page":"0600","DOI":"10.34133\/research.0600","volume":"8","author":"Y Tang","year":"2025","unstructured":"Tang, Y., Cai, Q., Tian, Z., Chen, W., & Tang, H. (2025). Crosstalk between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective. Research (Washington D C), 8, 0600. https:\/\/doi.org\/10.34133\/research.0600","journal-title":"Research (Washington D C)"},{"issue":"3","key":"5926_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J., & Bruni, D. (2019). Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nature reviews Drug discovery, 18(3), 197\u2013218. https:\/\/doi.org\/10.1038\/s41573-018-0007-y","journal-title":"Nature reviews Drug discovery"},{"issue":"1","key":"5926_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R., & Grivennikov, S. I. (2019). Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51(1), 27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"issue":"10","key":"5926_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nri3896","volume":"15","author":"NR West","year":"2015","unstructured":"West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015). Emerging cytokine networks in colorectal cancer. Nature reviews Immunology, 15(10), 615\u2013629. https:\/\/doi.org\/10.1038\/nri3896","journal-title":"Nature reviews Immunology"},{"issue":"7826","key":"5926_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2729-3","volume":"585","author":"A Janney","year":"2020","unstructured":"Janney, A., Powrie, F., & Mann, E. H. (2020). Host-microbiota maladaptation in colorectal cancer. Nature, 585(7826), 509\u2013517. https:\/\/doi.org\/10.1038\/s41586-020-2729-3","journal-title":"Nature"},{"issue":"6","key":"5926_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"138","author":"J Terzi\u0107","year":"2010","unstructured":"Terzi\u0107, J., Grivennikov, S., Karin, E., & Karin, M. (2010). Inflammation and colon cancer. Gastroenterology, 138(6), 2101\u20132114e5. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.058","journal-title":"Gastroenterology"},{"issue":"5","key":"5926_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"Knochelmann, H. M., Dwyer, C. J., Bailey, S. R., Amaya, S. M., Elston, D. M., Mazza-McCrann, J. M., & Paulos, C. M. (2018). When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cellular & molecular immunology, 15(5), 458\u2013469. https:\/\/doi.org\/10.1038\/s41423-018-0004-4","journal-title":"Cellular & molecular immunology"},{"issue":"8","key":"5926_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00109-024-02463-3","volume":"102","author":"MA Ortega","year":"2024","unstructured":"Ortega, M. A., Boaru, D. L., De Leon-Oliva, D., Fraile-Martinez, O., Garc\u00eda-Montero, C., Rios, L., Garrido-Gil, M. J., Barrena-Bl\u00e1zquez, S., Minaya-Bravo, A. M., Rios-Parra, A., \u00c1lvarez-Mon, M., Jim\u00e9nez-\u00c1lvarez, L., L\u00f3pez-Gonz\u00e1lez, L., Guijarro, L. G., Diaz, R., & Saez, M. A. (2024). PD-1\/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications. Journal of molecular medicine (Berlin Germany), 102(8), 987\u20131000. https:\/\/doi.org\/10.1007\/s00109-024-02463-3","journal-title":"Journal of molecular medicine (Berlin Germany)"},{"issue":"1","key":"5926_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40779-024-00586-9","volume":"11","author":"Y Godiyal","year":"2024","unstructured":"Godiyal, Y., Maheshwari, D., Taniguchi, H., Zinzuwadia, S. S., Morera-D\u00edaz, Y., Tewari, D., & Bishayee, A. (2024). Role of PD-1\/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy. Military Medical Research, 11(1), 82. https:\/\/doi.org\/10.1186\/s40779-024-00586-9","journal-title":"Military Medical Research"},{"key":"5926_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","volume":"7","author":"K Bardhan","year":"2016","unstructured":"Bardhan, K., Anagnostou, T., & Boussiotis, V. A. (2016). The PD1:PD-L1\/2 Pathway from Discovery to Clinical Implementation. Frontiers in immunology, 7, 550. https:\/\/doi.org\/10.3389\/fimmu.2016.00550","journal-title":"Frontiers in immunology"},{"issue":"4","key":"5926_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015). Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer cell, 27(4), 450\u2013461. https:\/\/doi.org\/10.1016\/j.ccell.2015.03.001","journal-title":"Cancer cell"},{"issue":"9","key":"5926_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei, S. C., Duffy, C. R., & Allison, J. P. (2018). Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer discovery, 8(9), 1069\u20131086. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0367","journal-title":"Cancer discovery"},{"key":"5926_CR27","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A., & Wolchok, J. D. (2018). Cancer immunotherapy using checkpoint blockade (Vol.,359 N.Y). Science (New York) 6382, 359, 1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science(New York 6382"},{"issue":"1","key":"5926_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","volume":"52","author":"PS Hegde","year":"2020","unstructured":"Hegde, P. S., & Chen, D. S. (2020). Top 10 Challenges in Cancer Immunotherapy. Immunity, 52(1), 17\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2019.12.011","journal-title":"Immunity"},{"issue":"4","key":"5926_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","volume":"11","author":"P Sharma","year":"2021","unstructured":"Sharma, P., Siddiqui, B. A., Anandhan, S., Yadav, S. S., Subudhi, S. K., Gao, J., Goswami, S., & Allison, J. P. (2021). The Next Decade of Immune Checkpoint Therapy. Cancer discovery, 11(4), 838\u2013857. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1680","journal-title":"Cancer discovery"},{"issue":"3","key":"5926_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M., & Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nature reviews Cancer, 2(3), 161\u2013174. https:\/\/doi.org\/10.1038\/nrc745","journal-title":"Nature reviews Cancer"},{"issue":"`1","key":"5926_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","volume":"2","author":"J Cathcart","year":"2015","unstructured":"Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015). Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes & diseases, 2(`1), 26\u201334. https:\/\/doi.org\/10.1016\/j.gendis.2014.12.002","journal-title":"Genes & diseases"},{"issue":"2","key":"5926_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.10329","volume":"99","author":"P Vihinen","year":"2002","unstructured":"Vihinen, P., & K\u00e4h\u00e4ri, V. M. (2002). Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. International journal of cancer, 99(2), 157\u2013166. https:\/\/doi.org\/10.1002\/ijc.10329","journal-title":"International journal of cancer"},{"key":"5926_CR33","doi-asserted-by":"publisher","first-page":"886996","DOI":"10.3389\/fmed.2022.886996","volume":"9","author":"X Jiang","year":"2022","unstructured":"Jiang, X., Jiang, Z., Jiang, M., & Sun, Y. (2022). Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Frontiers in medicine, 9, 886996. https:\/\/doi.org\/10.3389\/fmed.2022.886996","journal-title":"Frontiers in medicine"},{"key":"5926_CR34","doi-asserted-by":"publisher","first-page":"1874066","DOI":"10.3389\/fimmu.2026.1874066","volume":"17","author":"D Wang","year":"2026","unstructured":"Wang, D., Wang, Y., & Wang, X. (2026). Traditional Chinese medicine as a potential barrier-oriented sensitization strategy for immune checkpoint blockade in microsatellite-stable colorectal cancer: from resistance mechanisms to translational validation. Frontiers in Immunology, 17, 1874066. https:\/\/doi.org\/10.3389\/fimmu.2026.1874066","journal-title":"Frontiers in Immunology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05926-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:51:19Z","timestamp":1789703479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":34,"alternative-id":["5926"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05926-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"7 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal care, sacrifice protocols, and experiments performed were carried out with the approval of the Institutional Animal Ethics Committee (IAEC), Guang\u2019anmen Hospital Animal Care and Use Committee of the Chinese Academy of Chinese Medical Sciences (NO: IACUC-GAMH-2019-012). All methods were carried out in accordance with relevant guidelines and regulations. This study was conducted in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines, ensuring transparent and comprehensive reporting of all in vivo experiments.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study participants provided consent for the data to be published.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}